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DECREASED PARVALBUMIN MRNA EXPRESSION IN CEREBELLAR 
PURKINJE CELLS IN AUTISM 
SUJITHRA REPRAKASH  
ABSTRACT 
Earlier human and animal studies have indicated abnormal striatal GABAergic 
interneurons relating to autism spectrum disorder’s (ASD) core features such as 
stereotypic repetitive behaviors, impaired language and motor skills, and social 
interactions. Purkinje cells (PCs) in the cerebellum are of great interest in ASD; 
earlier research has reported a loss of PCs, irregularities within deep cerebellar 
nuclei, a lower level of GAD67 (glutamic acid decarboxylase) mRNA expressed 
on PCs, and reduced parvalbumin (PV)-positive interneurons in cortex and 
hippocampus. In this study, in-situ hybridization was used to quantify the levels of 
PV mRNA in PCs in post-mortem human autism and control cerebellum sections. 
Two-tailed t-test analysis of the data showed a significant decrease (p<0.05) in 
PV mRNA level on PCs in autism compared to control sections. In addition, when 
comparing two groups (seizure and no seizure) in autism sections, no statistical 
significance was observed. Post-mortem interval (PMI) and age was compared 
between the PV mRNA levels in autism and control. Only weak negative 
correlation was found among age and PV mRNA levels in both groups. This 
report of decreased PV mRNA level in autism cases further supported previous 
research findings related to PCs and also confirmed interference with the 
vii 
 
inhibitory function of PCs to deep cerebellar nuclei and the cortex resulting in 
behavioral and motor impairments in ASD.   
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INTRODUCTION 
What is Autism? 
Autism spectrum disorder (ASD) is a neurodevelopment disorder 
characterized by symptoms such as deficiency in social communication and the 
ability to develop and maintain relationships. ASD severity is determined from the 
intensity of stereotypic and repetitive behaviors and from the extent of social 
communication deficits. Symptoms of ASD are present from early childhood, and 
ASD is very often comorbid with intellectual disability (DSM-V, APA, 2013). 
Children with ASD also exhibit impaired development of motor skills and praxis 
(Qiu, Adler, Crocetti, Miller, & Mostofsky, 2010). Reports indicate that 1 in 88 
children are diagnosed with ASD in the US, and prevalence rate is higher in 
males than females (Halladay et al., 2015; Thurm & Swedo, 2012). Epilepsy is 
also found to be a comorbid disorder frequently associated with ASD. In a study 
of 118 individuals diagnosed with infantile autism (IA) and 336 controls, epilepsy 
was significantly higher among the IA group (Mouridsen, Rich, & Isager, 2011). In 
a general population, epilepsy has a 2-3% incidence rate while normally it is 30% 
among ASD cases (Tuchman & Rapin, 2002). In a separate study, the 
prevalence rate of epilepsy was 19.44% in children with ASD (Kohane et al., 
2012). However, when looking at the prevalence rate of ASD in children with 
epilepsy, one study found 32% of epileptic children fit the ASD criteria (Clarke et 
al., 2005). Nevertheless, a different study done by Matsuo and colleagues 
reported only 15.2% of their epilepsy cases had ASD, which is much lower than 
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the previous study mentioned (Matsuo, Maeda, Sasaki, Ishii, & Hamasaki, 2010). 
ASD is a rather heterogeneous disorder that is a result of genetic, 
neurobiological, and environmental interactions during primary brain 
development (Kong et al., 2014). While the causes of autism are widely being 
explored, no specific causation for ASD has been identified. 
Even though both genetic and environmental factors are implicated in 
ASD, 90% of ASD cases are categorized as idiopathic and only 10% of the cases 
have been linked with genetic mutations (Zafeiriou, Ververi, Dafoulis, Kalyva, & 
Vargiami, 2013). Some of the major genetic variations linked to ASD are Fragile 
X syndrome (FXS), tuberous sclerosis complex (TSC), Rett syndrome, and 
neurofibromatosis type 1 (NF1) (Takano, 2015). Another important genetic 
marker of ASD is Shank 2 and 3 deletion syndromes. Genetic variations within 
Shank 3, genes involved in TSC, neuroligins 3 and 4 (NLGN3; NLGN4) are 
implicated in idiopathic ASD (Kelleher et al., 2012). Other whole-genome 
microarray research reported that deletions and duplications known as copy 
number variation (CNV) were seen in 5%-10% of ASD cases (Betancur, 2011). 
Kohane and his colleagues reported that FXS and TSC occur in 0.5% and 0.8% 
in ASD cases (Kohane et al., 2012). This is consistent with previous studies 
showing that the genetic mutations underlying ASD are not common within the 
population. When looking at the comorbidity of ASD in individuals with FXS and 
TSC, the rate was 30% and 50-61% correspondingly (Kong et al., 2014). One 
curious finding is the prevalence rate of epilepsy in these genetic syndromes. 
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According to Tuchman and Rapin, the seizure risk can be up to 94% in Rett 
syndrome. They also stated that in some of the genetic syndromes involving 
inheritance, autism and epilepsy do occur side by side (Tuchman & Rapin, 2002). 
When looking at ASD cases, the occurrence of TSC is uncommon; however, it is 
more common when epilepsy and ASD are both present in these cases (Spence 
& Schneider, 2009).      
FXS patients have mutations in the FMR1 gene where there is a 
decreased production of Fragile X Mental Retardation Protein (FMRP). This 
protein binds to RNA that is involved in brain synaptic plasticity, long term 
potentiation, and learning and memory (Uzunova, Hollander, & Shepherd, 2014). 
The abnormalities found in the brain due to the lack of FMRP are seen in various 
regions of the brain in both excitatory and inhibitory pathways such as the 
amygdala, the hippocampus, the striatum, and the cerebral cortex (Takano, 
2015). Other small cellular irregularities were also found in autopsy studies in the 
cerebellum (Tuchman & Rapin, 2002). In FXS cases linked to ASD, many brain 
areas are affected, but the main region of interest is the cerebellar vermis lobules 
VI-VII. Patients with FXS who are not diagnosed with ASD do not share these 
abnormalities found in the cerebellar regions, but patients with ASD do share this 
aspect (Fatemi et al., 2012). In particular, altered parieto-temporal lobe, 
cerebellar cortex, striatum, frontal cortex, and hypothalamus were strongly 
associated in mouse models of ASD (Ellegood et al., 2015). Phenotypically, FXS 
patients exhibits not only hyperactivity, attention deficits, aggression, but also 
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intellectual disability in males who have the full mutation (Zafeiriou et al., 2013). 
Furthermore, ASD was reported in FXS cases that had pre-mutation along with 
slight cognitive defects and normal IQ (Moss & Howlin, 2009). Pre-mutations are 
carriers that do not exceed certain amount of CGG repetitions in FMR1 gene and 
do not express FXS completely (Greco et al., 2002).  
The tuberous sclerosis complex (TSC) is another genetic syndrome that 
has been associated with ASD. Not only is it linked with ASD, but also it is 
implicated with cerebellar abnormalities (Fatemi et al., 2012). TSC is an 
autosomal dominant disorder which affects many systems in the body and occurs 
by alterations with the TSC1 or TSC2 genes; these genes are responsible for the 
transcription of the proteins hamartin or tuberin (Takano, 2015). Other 
characteristics also include tumors, neurological deficits, epilepsy and cognitive 
dysfunctions. Mutations in the TSC genes lead to abnormalities within the 
rapamycin complex 1 activation (mTORC1), which is responsible for cell growth 
and protein translation (Uzunova et al., 2014). GABA interneurons dysfunction 
was also suspected in individuals with TSC, epilepsy, and ASD when a GABA-
potentiating agent, vigabatrin, was introduced and those individuals had infantile 
spasms. Other studies found that the deletion of TSC1 gene increased mTORC1 
signaling in GABAergic interneurons in the cortex and hippocampus, and 
Purkinje cells degenerated in TSC mouse model with Purkinje cell-TSC2 deletion 
(Takano, 2015). This showed further evidence that TSC1/TSC2 genes and 
GABAergic interneurons may play a role in ASD and epilepsy. When looking at 
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the neurofibromatosis type 1 (NF1) in ASD patients, the prevalence rate is 
approximately 1.2% which is smaller than other genetic syndromes and ASD. 
However, the prevalence rate of ASD in patients with NF1 is 4%. Phenotypic 
features associated with NF1 include behavioral deficits, learning impairment, 
and attention-deficit hyperactive disorder (Zafeiriou et al., 2013). Learning 
disability is reported in about 50% of individuals with NF1. NF1 is an autosomal 
dominant disorder that occurs due to mutations within the NF1 gene; this gene 
encodes for neurofibromin, mainly expressed in Schwann cells, 
oligodendrocytes, and neurons. The neurofibromin activates the Ras-GTPase 
pathway and help with the regulation of mTORC1 (Takano, 2015). When 
mutations occur with the NF1 gene, mTORC1 is not very well regulated similar to 
TSC syndrome.      
In Rett syndrome patients, which have similar deficits as ASD, gene 
mutations that are responsible for methyl-CpG binding protein 2 (MeCP2) causes 
impairment with language and motor skills. These individuals develop ataxia, 
cognitive deficits, seizures, and stereotypic hand movements (Ito-Ishida, Ure, 
Chen, Swann, & Zoghbi, 2015). One mice study explored the loss of MeCP2 
from GABAergic interneurons in the cortex and striatum; they found that the mice 
with the deletion had impaired motor coordination, stereotypic repetitive 
behaviors and other features relating to Rett syndrome. They also had a 
decrease in GABA release associated with a loss of MeCP2 in GABAergic 
interneurons which may lead to hyperexcitability (Chao et al., 2010). Additionally, 
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loss of MeCP2 gave rise to smaller soma within calretinin-, parvalbumin-, and 
somatostatin-positive cortical interneurons. Compared to neurons that are not 
GABAergic, GABAergic interneurons have more MeCP2 protein levels (Takano, 
2015). One interesting aspect would be the subtypes of interneurons and the loss 
of MeCP2 with Rett’s phenotypic features. Mice that lacked the production of 
MeCP2 protein in PV-positive and somatostatin-positive interneurons showed the 
most phenotypic features of Rett syndrome (Ito-Ishida et al., 2015). Moreover, 
changes in the GABAA receptor have been seen in mouse models of Rett 
syndrome phenotypes and few other genetic syndromes. There was a decreased 
subunit β3 expression in GABAA receptors in individuals with Rett syndrome and 
were also seen in ASD cases (Eagleson et al., 2010). These studies further 
emphasize the significance of MeCP2 protein and GABAergic signaling found in 
the brain. Thus, investigating these genes closely by using specific agonists or 
antagonists would reveal more about GABAergic interneurons and the 
mechanisms involved in ASD. Correspondingly, there is a strong comorbidity 
between genetic mutations, epilepsy, and ASD, so looking at the interactions 
between the mutations and signaling more closely would reveal additional 
information about syndromic ASD and idiopathic ASD even though only a small 
percentage of ASD is associated with genetic syndromes. Ultimately, 
investigating the pathophysiological components of each genetic mutation would 
be valuable to understand all aspects of ASD and to conceive newer treatments 
for ASD.   
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Basal Ganglia and Autism: GABA 
Invasive habits and rituals that dominate daily life can be seen in 
neuropsychiatric disorders such as ASD, and especially in Rett syndrome. Over 
the years, studies have shown that the basal ganglia circuitry is mainly involved 
in the acquisition of habits and repetitive behaviors. Impaired activity in these 
circuits may be a factor in neurological disorders (Graybiel, 2008). One of the 
core features of ASD is repetitive and stereotypic behaviors. Some neural 
pathways related to the deficits seen in ASD are considered to be the 
dorsolateral prefrontal cortex projection to the caudate head and medial inferior 
frontal gyrus to ventromedial caudate and to dorsal globus pallidus (GP). Lesions 
to these particular areas has been linked to social impairments. Additionally, 
cognitive impairments in ASD has been connected to neural pathways involving 
the thalamus (Schuetze, Park, Cho, MacMaster, & Chakravarty, 2016). Using 
MRI, shape irregularities were reported in the basal ganglia in children with ASD. 
Decreased motor skills were associated with the abnormalities in the right 
posterior putamen along with decreased praxis in the bilateral anterior and 
posterior putamen. Another observation made in the same study was the 
association between bilateral medial caudate head deformation and higher social 
impairment (Qiu et al., 2010). Dyspraxia was highly correlated with social, 
communication, and behavioral impairments in high functioning children with 
ASD (Jeste, 2011). Although the majority of MRI studies have reported that the 
striatum, pallidum, and thalamus in cases with ASD were larger than in the 
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control subjects, some researchers reported the opposite or no significance 
between the two groups (Schuetze et al., 2016).      
The basal ganglia consist of subcortical nuclei that play a role in motor, 
associative, cognitive, mnemonic, and limbic functions. There are several 
structures in the basal ganglia such as the striatum, the globus pallidus (GP) in 
mice also known as globus pallidus externus in primates (GPe), the 
entopenduncular nucleus (EP) in mice or globus pallidus internus (GPi) in 
primates, the subthalamic nucleus (STN), nucleus accumbens, and the 
substantia nigra (SN) which has two parts: pars compacta (SNc) and pars 
reticulata (SNr) (Bolam et al., 2000). In primates and cats, the striatum is made 
up of two parts: caudate and putamen and in between them is the internal 
capsule. The striatum receives input projections from the cortex mostly while the 
globus pallidus or GPe and the SNr project outside the basal ganglia (Albin, 
Young, & Penney, 1989). Even though, the striatum receives substantial input 
from the cortex, some cortical projections also relay information to the STN. The 
information received by the striatum is assimilated from other areas such as 
amygdala, hippocampus, intralaminar thalamic nuclei, and dorsal raphe (Bolam 
et al., 2000). All of these structures are involved in the direct and indirect 
pathways that regulate the thalamocortical circuitry.  
The direct and indirect pathways are briefly summarized in figure 1 in the 
context of striatum, SNr, SNc, STN, ventral anterior and ventral lateral nuclei of 
thalamus (VA/VL), and cortex. The striatum mostly contains spiny neurons while 
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the pallidum consists of aspiny neurons (Yin & Knowlton, 2006). It has been 
suggested that interneurons play a crucial role in controlling hyperexcitability; 
dysfunction with these interneurons has been linked to epilepsy, higher risk of 
seizures, TSC, and Rett syndrome (Takano, 2015). Although both projection 
neurons and different types of interneurons exist in the striatum and are 
GABAergic, about 90-95% of the neurons are medium size densely spiny 
neurons. To communicate, these neurons use gamma-aminobutyric acid (GABA) 
as their main neurotransmitter. Additionally, the cortical input received by the 
spiny neurons are regulated by local striatal interneurons and by SNc inputs 
(Bolam et al., 2000).  
Studies have indicated that aberrant GABAergic pathways are linked to 
ASD. The researchers observed decreased levels of GAD67 (Glutamic acid 
decarboxylase) mRNA in Purkinje cells (PCs) of ASD cases; GAD67 is one of the 
isoforms that is prominent in PCs, and this enzyme produces the 
neurotransmitter GABA from glutamate which is used for excitatory signaling 
(Yip, Soghomonian, & Blatt, 2007). Furthermore, Zhang and his associates 
illustrated that mice deficient of GAD67 in striatal neurons expressing Gpr88 
protein demonstrated social impairments such as repetitive grooming and 
learning impairments (Zhang, Hill, Labak, Blatt, & Soghomonian, 2014). This 
conclusion is consistent with the notion of abnormal GABAergic interneurons in 
the pathology of ASD.   
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Interneurons 
 A small percentage that make up the striatal neurons are interneurons. 
These GABAergic interneurons have different subpopulations, but the main 
population expresses parvalbumin (PV), a calcium binding protein, and have a 
high rate of firing (Bolam et al., 2000). Calcium ions (Ca2+) are crucial for signal 
transmission in the brain through intracellular and transmembrane transport as 
well as neurotransmitter release, regulation of gene expression, synaptic 
plasticity, and axonal elongation. Some of these functions are regulated by 
calcium binding proteins during neuronal differentiation and development (Ulfig, 
2002). There are over 250 types of calcium binding proteins in the body, and PV 
is one of the most well-known in the central nervous system. Along with calretinin 
(CR) and calbindin (CB), PV is involved in calcium homeostasis in subtypes of 
neurons and in buffering of Ca2+. GABAergic interneurons in the cerebral cortex 
such as chandelier and basket cells also expresses PV (Eyles, McGrath, & 
Reynolds, 2002). Thus, these calcium binding proteins are used as biomarkers to 
investigate the neuroanatomy of the brain. In addition, PV is expressed during 
later in brain development and has been mostly linked with mature neurons while 
the other two are expressed during early brain stages (Ulfig, 2002).  
One study looked at the morphological properties of GABAergic 
interneurons in the somatosensory cortex of FMR1 KO and wild type mice. They 
reported a substantial decreased amount of PV-positive interneurons and larger 
soma size of PV neurons in KO mice (Selby, Zhang, & Sun, 2007). This further 
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illustrates the important connection between GABAergic inhibitory system and 
ASD. As mentioned earlier, mutated SHANK genes seem to play an important 
role in ASD since ASD features were often associated with mutated SHANK1, 
SHANK2, and SHANK3. PV-positive interneurons were reduced by 20-25% in 
the previous human with ASD and mouse models of ASD studies even though 
the gene that encodes for PV (PVALB) was not altered (Filice, Vörckel, Sungur, 
Wöhr, & Schwaller, 2016). Several research studies involving genetic mutations 
and calcium conductance in humans have been associated with the 
pathophysiology of ASD. Plasma membrane calcium ATPases (PMCAs) 
transport calcium from the cytoplasm to the extracellular space during signaling. 
The ATP2B2 gene that encodes for PMCAs is normally found in the dendritic 
spines of PCs and in PV-positive GABAergic interneurons. Variants for this gene 
indicated a lower expression of PMCAs in post-mortem males with ASD (Fatemi 
et al., 2012). In a mice study that investigated a gene encoding for the 
homeobox-containing transcription factor, Engrailed-2 (En2), and the GABAergic 
interneurons, the researchers detected decreased interneurons expressing PV, 
somatostatin, and neuropeptide Y in the En2 knockout mice cortex and 
hippocampus. The En2 knockout mice also exhibited lower PCs in the 
cerebellum and amygdala abnormalities in previous animal studies (Sgadò et al., 
2013). An additional mice study which looked at Ca2+ dependent activator protein 
for secretion 2 (CADPS2) and brain-derived neurotropic factor (BDNF) supported 
GABAergic interneuron dysfunction in ASD. Mutations of the gene encoding for 
12 
 
CADPS2 resulted in impaired BDNF release. Since BDNF is crucial for 
differentiation of PV-positive cortical interneurons, they reported that PV-positive 
interneurons in the neocortex and hippocampus were significantly lower than 
wild-type mice and the affected mice had behavioral phenotypes similar to ASD 
features (Sadakata, 2007). In this same study, they reported another important 
implication relating to ASD neuropathology. Purkinje cells expressing CB were 
reduced in the CADPS2 knockout mice. By introducing exogenous BDNF, the 
viability of PCs increased significantly which also reinforced the importance of 
BDNF for PC functionality in the cerebellum and calcium signaling (Sadakata, 
2007). Wöhr and other colleagues found that PV knockout mice exhibited 
phenotypic features of ASD such as impairment with social interactions and 
communication and repetitive behavior. Even heterogeneous mice group 
presented social and communication deficits which indicated ASD features can 
result from lower expression of PV (Wöhr et al., 2015). An earlier 
immunohistochemistry study showed strong PV antiserum labeling on all PCs in 
rats. They also found PV antiserum labeling on stellate and baskets cells which 
are found in the molecular layer of cerebellum which was opposite of granule 
cells in the granular cell layer (Celio & Heizmann, 1981). There are obvious links 
between PV-positive interneurons and ASD pathology, but how exactly PV plays 
a role in the pathophysiology is yet to be determined.    
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Cerebellum Pathophysiology 
Post-mortem FXS brains with pre-mutation or carriers of FXS showed 
cerebellar neurodegeneration, a decrease in Purkinje cells (PC), swelling of PC 
axons, and spongiosis of white matter in the cerebellum (Greco et al., 2002). PC 
loss in the cerebellum has been shown in various early studies of ASD. This loss 
is mostly seen in the lateral hemispheric region of the cerebellum cortex. In this 
region, 75% of ASD cases showed a significant loss of PCs (Hampson & Blatt, 
2015). In a clustering analysis done in animal models for ASD, Ellegood et al. 
reported three circuits associated with ASD: cortex to basal ganglia, brain 
regions for social interaction and autonomic regulation, and cerebellum (Ellegood 
et al., 2015). Loss of PCs were mainly in the posterolateral neocerebellar cortex 
and nearby archicerebellar cortex of cerebellar hemisphere. Not only PCs were 
abnormal, but irregularities were also found within the deep cerebellar nuclei 
(Fatemi et al., 2012).   
As shown in Figure 2, the PCs are the main output neurons in cerebellum. 
Both climbing fibers from inferior olivary nucleus (ION) and parallel fibers from 
granule cells (GCs) provide excitatory input to PCs (Yip et al., 2007). The 
cerebellum has three layers starting from inner to outer layer: granular cell layer 
(GCL), Purkinje cell layer (PCL), and molecular layer (ML). In the granular layer, 
the granule cells provide excitatory input to the Purkinje cell in the molecular 
layer via parallel fibers. The climbing fibers from the inferior olivary nucleus also 
gives excitatory input to the Purkinje cells in the molecular layer. Mossy fibers 
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from the pontine nuclei, spinal cord, and vestibular system carry excitatory input 
to the granule cells and the deep cerebellar nuclei. The climbing fibers also give 
excitatory input to the deep cerebellar nuclei. The deep cerebellar nuclei receive 
inhibitory input from PCs in the Purkinje cell layer. The information from the deep 
cerebellar nuclei will then travel to brainstem, the thalamus, premotor, and motor 
cortices (Hampson & Blatt, 2015).        
In this study, PCs in human post-mortem cerebellum tissue samples from 
11 cases with ASD and 11 controls were compared and analyzed. By utilizing the 
in-situ hybridization methodology, parvalbumin mRNA on PV-expressing PCs 
was labeled. Once labeled, the level of PV expression (no. of pixels/µm2) on the 
PCs was measured blindly and statistically analyzed for any significance 
between control and ASD groups. Other properties such as post-mortem interval 
(PMI) and age were also analyzed within each group. Analysis of seizures was 
only completed in the autism group since controls did not have any reported 
seizures. My thesis was completed to explore the pathology of PCs in human 
cerebellum of ASD. By looking at the expression of PV in the cerebellum, this 
study may encourage future research about the specific role of PV and Calcium 
signaling in interneurons and PCs which may lead to more specific treatments to 
improve the main symptoms of ASD.  
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Figure 1. Direct and Indirect Pathways. In direct pathway, information relays 
from striatum (C+P) to GPi/SNr and then to thalamus (VA/VL) whereas 
information from striatum go to GPe and STN before going to GPi/SNr in indirect 
pathway. The negative and positive signs mean inhibitory and excitatory signals, 
respectively.  
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Figure 2. Cerebellum Structure 
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METHODS 
 
Subjects and Tissue Preparation 
 For this study, 44 post-mortem cerebellum sections were obtained from 11 
controls and 11 cases diagnosed with ASD. Two adjacent sections were 
processed from each case, so the total number of sections used per group was 
22. The tissue samples were stored in a -80˚C freezer before using them for the 
experiment. The tissue samples were collected along with age, post-mortem 
interval (PMI), and history of seizures presented in table 1.  
   
Linearization of Parvalbumin DNA 
First step was to linearize a transcription vector pPCR-Script AMP SK(+) 
that included the human parvalbumin complementary DNA (cDNA). The vector 
plus a restriction enzyme, SacI, was incubated at 37˚C for 2 hours. In order to 
confirm the linearization was successful, gel electrophoresis was run with 1µL 
aliquots of uncut cDNA, cut cDNA before extraction, and cut cDNA after 
extraction on 0.8% Agarose gel at 75 Volts for 35 minutes (Lanoue, Blatt, & 
Soghomonian, 2013) 
 
Synthesis of 35S Labeled RNA Probes  
 After the linearization step, the parvalbumin DNA (cDNA) was stored at -
20˚C until the experiment. During day 1 of in-situ hybridization, 35S radiolabeled 
complimentary RNA probe was transcribed from the linearized cDNA. For this in 
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vitro transcription step, 2.5µM 35S-uracil triphosphate (UTP; specific activity 1250 
Ci/mmol; PerkinElmer Life Sciences, Boston, MA) and 10 µM unlabeled UTP with 
adenosine triphosphate (ATP), cytosine triphosphate (CTP), and guanine 
triphosphate (GTP) were added to the linearized parvalbumin cDNA and then 
with the RNA polymerase T7 for 2-hour incubation at 37˚C. The cDNA template 
was broken down by adding DNAse I enzyme. The radioactive cRNA probe was 
extracted using phenol/chloroform combination and ethanol precipitation. Alkaline 
hydrolysis was completed for 38 minutes at 60˚C to shorten the length of the 
cRNA probe, so the accessibility of the probe during hybridization is better (Cox, 
DeLeon, Angerer, & Angerer, 1984; Yip, Soghomonian, & Blatt, 2007).  
 
In-situ hybridization  
For day 2, the protocol was performed as described in a previous study 
Soghomonian et al., 1994. The tissue samples stored in -80˚C were defrosted 
under the hood and then fixed in 3% paraformaldehyde. Then, the sections were 
sequentially washed in 2 x SSC, 0.1M PBS, 0.1M Triethanolamine, and acetic 
anhydride, and 1.0 M tris-glycine. In order to dehydrate the sections, they were 
then immersed in 70%, 80%, and 95% ethanol. Adequately sized coverslips were 
cut from parafilm with scissors cleaned with 100% ethanol. 7ng of probe mixed in 
with hybridization solution (40% formamide, 10% dextran sulfate, 4x SSC, 10mM 
dithiothreitol, 1.0% sheared salmon sperm DNA, 1.0% yeast tRNA, 1x Denhardt’s 
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solution) were applied on each section. During hybridization, the tissue sections 
were incubated for 4 hours at 52˚C.  
After 4 hours, the cover slips were removed by immersing them in 2x SSC 
and the sections washed in a new 2x SSC solution. Post hybridization 
incubations included 50% formamide in 2x SSC for 25 minutes in the 52˚C water 
bath, 2x SSC washes, RNAse A for 30 minutes in the 37˚C water bath, 50% 
formamide in 2x SSC wash again for 5 minutes. Finally, the sections were left 
overnight in 2x SSC with 0.05% Triton X. On day 3, sections were consecutively 
washed in 2x SSC with 0.05% Triton X, 300mM ammonium acetate, 70% and 
80% ethanol/300mM ammonium acetate, 95% ethanol, xylene, and 100% 
ethanol. Once the sections were dry, they were placed in a metal cassette. In a 
dark room, Kodax Biomax-MR X-ray films were set on top of the sections to 
capture the exposure of the radioactivity of the tissue. The metal cassettes were 
covered in aluminum foil in the dark to ensure no light exposure. The films were 
exposed for 16 days and developed.  
 
Emulsion radioautography 
Emulsion procedure was completed in a dark room. Slides were dipped in 
Kodak TB3 nuclear emulsion melted in a 37˚C water bath. Then sections were 
left to dry for 3 hours. They were then placed in slide boxes that were light tight 
and had desiccant beads. The boxes were covered in aluminum foil to keep light 
out completely. After 21 days of exposure, the emulsion covered slides were 
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developed in D19 solution on ice at 13˚C-15˚C. Slides were developed by 
immersing them in D19 for 3.5 minutes and fixed for 4 minutes. After 
Hematoxylin and eosin (H&E) staining, coverslips were placed on the slides 
using Eukitt (Sigma-Aldrich Chemicals, St. Louis, MO).  
 
Quantitation 
Emulsion radioautographs were analyzed under bright field microscopy 
with a 60x objective. The images of labeled neurons were captured using a Sony 
CCD video camera and Macintosh computer and analyzed in Image J software 
(NIH image). There were two slides per subject and 50 Purkinje cells per section 
were quantified. An identical circular outline was used for each Purkinje cell for 
measuring the area covered by silver grains. The area covered by silver grains 
was expressed as a number of pixels per cell. The quantitation was carried out 
by an experimenter blind to the experimental groups. In addition, sections were 
analyzed in random in order to avoid biases. Furthermore, on the first slide 
analyzed, the number of grains was counted manually and the corresponding 
number of pixels measured. This was carried out in order to demonstrate a linear 
relationship between the two measures was found. This validated our 
computerized analysis by showing that the area covered by silver grains was 
correlated with the number of silver grains. The collected numbers of pixels per 
cell for each slide were then averaged per subject and then compared between 
autism and control subjects. After isolation of the data into two groups, a two-
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tailed t-test was performed in Prism 7th Ed, 2016. During the comparison, few 
assumptions were made about the silver grains as follows: (1) the silver grains 
expressed intracellular parvalbumin mRNA content and the number of silver 
grains was proportional to the amount of radioactivity in each cell, (2) 
parvalbumin mRNA was only in the Purkinje cell soma, and (3) hybridization did 
occur in the Purkinje cell soma (Lanoue et al., 2013; Yip et al., 2007).  
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Table 1. Case Information with Age, PMI, History of Seizures 
Cases Group Age PMI Seizure Cause of Death Gender 
4268 Control 30 22 -- Cardiomyopathy unknown 
4104 Control 24 5 N Gun shot - chest M 
4271 Control 19 21 -- Epiglottitis/unknown M 
5251 Control 19 18.6 N Pneumonia M 
5718 Control 22 21.5 N Unknown M 
4364 Control 27 -- N Accident M 
4272 Control 19 17 N Accident M 
4188 Control 16 13 N Unknown M 
4362 Control 25 -- N Accident M 
4275 Control 20 16 N Accident M 
4267 Control 26 20 N Accident M 
6401 Autism 39 14 N Cardiac 
Tamponade 
M 
4899 Autism 14 9 Y Drowning M 
5176 Autism 23 18 N Subdural 
Hemorrhage 
M 
1401 Autism 21 20 N Pneumonia F 
1484 Autism 19 15 N Burns/unknown M 
5754 Autism 20 29.98 -- Unknown M 
5278 Autism 15 13 Y Drowning F 
6677 Autism 30 16 N Congestive Heart 
Failure 
M 
3511 Autism 27 16 Y Train Accident M 
3845 Autism 31 28.4 Y Pancreatitis/cancer  M 
6337 Autism 22 25 Y Aspiration/Choked M 
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RESULTS 
 
 
A) Decreased parvalbumin mRNA levels found in autism cerebellum post-
mortem tissue  
 
Parvalbumin mRNA labeled with the 35S Parvalbumin probe was 
represented by clusters of silver grains as shown in figure 3. More silver grains 
were visually observed in PC found in control sections (Figure 3B). Once 
identified on the Purkinje cells in both groups, the silver grain densities were 
measured as number of pixels with Image J software. The same circular outline 
was used for every Purkinje cell in both autism and control sections. 100 Purkinje 
cells were quantified for each case and mean averages were calculated (Table 
2). There were 11 controls and 10 autism sections. One outlier was identified and 
removed from the autism group using Prism 7th Ed, 2016. The mean mRNA 
levels for autism and control were 114.7 ± 14.48 and 228.2 ± 46.75, respectively. 
Two-tailed T-test Analysis of these densities showed a significant decrease in 
parvalbumin mRNA levels in autism compared to the control group (Figure 4).  
 
B) Analysis of parvalbumin mRNA levels in Autism cases with reported history of 
seizure and no seizure  
 
 There were 5 cases that reported no seizure and 5 cases that reported 
seizures. One outlier was removed within the seizure group before analysis. The 
mean ± SEM values for PV mRNA levels in no seizure and seizure groups were 
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127.5 ± 27.62 and 100.1 ± 12.68 (Table 3). Two tailed t-test analysis of the PV 
mRNA mean values exhibited no significance (Figure 5).   
 
C) Correlation results between age, PMI, and average parvalbumin mRNA levels 
in autism and control 
To look further into age and PMI, a correlation analysis was performed 
between age, PMI, and average PV mRNA levels in both groups. As shown in 
figure 6, no correlation was observed between PMI and mRNA levels in neither 
groups. However, a negative relationship was observed between age and PV 
mRNA levels within autism and control sections (r = -0.3743 and r = -0.2335, 
respectively), but this observation was not statistically significant.     
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Figure 3. Photographs of Purkinje cell (arrows) in cerebellum under 60X after in 
situ hybridization with radiolabeled S35 parvalbumin RNA probes, developed with 
emulsion, and stained with H&E. Figure 3A represents the silver densities found 
in a PC of an autism section. Figure 3B represents the PC found in a control 
section. Identical circular outline surrounding only the cell was used to measure 
the densities in both sections. Any outside silver grains were considered artifact 
and were not included in the measurements.   
26 
 
Table 2. The mean values of S35 labeled PV mRNA levels from 100 Purkinje 
cells (PCs) for each case subject. Mean ± SEM is included for autism and control 
 
 
Autism Case 
Number (n=10) 
Mean mRNA 
Levels 
Control Case 
Number (n=11) 
Mean mRNA 
Levels 
6401 98.23 4268 247.46 
4899 133.32 4104 234.84 
5176 138.15 4271 594.4 
1401 197.94 5251 128.07 
1484 164.64 5718 80.01 
5754 108.97 4364 70.84 
5278 92.61 4272 423.38 
6677 38.38 4188 147.77 
3511 102.22 4362 192.83 
6337 72.43 4275 171.18 
  4267 219.45 
Mean ± SEM 
114.7 ± 14.48 
(*p<0.05) 
 228.2 ± 46.75 
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Figure 4. Average parvalbumin mRNA levels in Purkinje cells labeled with 35S 
RNA probe and represented as number of pixels in control and autism groups. 
The average found for control was 228.2 ± 46.75, (n=11) and for autism was 
114.7 ± 14.48, (n=10). Two tailed t-test analysis showed a significance between 
two group (*p<0.05).   
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Table 3. Mean values of PV mRNA levels in autism cases with reported seizures 
and no seizures.  
 
Case Number No Seizure (n=5) Case Number Seizure (n=4) 
6401 98.23 4899 133.32 
5176 138.15 5278 92.61 
1401 197.94 3511 102.22 
1484 164.64 6337 72.43 
6677 38.38   
Mean ± SEM 127.5 ± 27.62  100.1 ± 12.68 
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Figure 5. The levels of PV mRNA measured on the Purkinje cells in autism is 
represented by number of pixels. The autism group was further divided in two 
groups; patients with a history of seizure (n=5) and no seizure (n=4). Two tailed t-
test analysis of the means showed no significance.      
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Figure 6. PV mRNA levels were compared in both autism and control groups 
according to age and post-mortem interval values. Figure 6A & 6C exhibits the 
correlation between age, PMI, and mRNA levels in autism (n=10). Figure 6B & 
6C represents correlation between age (n=11), PMI (n=9) and mRNA levels in 
control. Weak negative correlation was found between age and PV mRNA levels 
in autism and control, while no correlation was found between PMI and mRNA 
levels in neither groups.     
  
31 
 
DISCUSSION 
 
Analysis of the mean values found on Purkinje cells (PCs) showed an 
overall decreased PV mRNA level in the autism cerebellum sections. 
Additionally, Yip and other colleagues established in situ hybridization data 
indicating a lower level of GAD67 mRNA on Purkinje cells in autistic cerebellum 
(Yip et al., 2007). Further examination by Yip et al. indicated that GAD67 mRNA 
levels in interneurons in the cerebellum molecular layer (Stellate and Basket cells 
– Figure 2) were higher in autism than control cases. These interneurons provide 
inhibitory input to PCs which then send inhibitory signaling to deep cerebellar 
nuclei (Yip, Soghomonian, & Blatt, 2008). Higher expression of GAD67 in these 
cells may contribute to the decreased GAD67 mRNA levels found in PCs, which 
ultimately interrupts cerebellar output function of PCs and deep cerebellar nuclei 
transmission. Although the number of labeled PCs in the cerebellum was not 
investigated in this study, it may be interesting to determine if a loss of PCs 
occurs as has been described in earlier ASD studies (Hampson & Blatt, 2015). 
There was no correlation found between PMI and mRNA levels in neither autism 
nor control (Figure 6C & 6D). According to Yip et al., post-mortem tissue has very 
stable RNA (Yip et al., 2008). This supports the notion that the post-mortem 
period does not affect mRNA quality considerably. On the contrary, a trend for 
negative correlation was found for both groups when age was compared with the 
level of PV mRNA (Figure 6A & 6B). Since this trend was not significant, it can be 
concluded that age may not greatly affect mRNA levels in either groups.  
32 
 
Since epilepsy and seizures have been strongly associated with 
dysfunction of GABAergic interneurons (Takano, 2015), additional analysis of 
autism cases with reported seizures and the levels of PV mRNA was performed 
in order to explore the link between seizures and physiological changes within 
PCs. The analysis revealed no significance between the two means found within 
the autism group (Table 3; Figure 5). Although no significant difference was 
established between the PV mRNA levels on PCs, a closer look at table 1 
revealed that about half of the autism cases (n=5) had a history of seizures while 
almost 80% of control cases did not. The no seizure group had a slightly higher 
mean value but this was not significant. However, it may be worth considering a 
bigger autistic population sample looking specifically at the connection between 
seizures and expression of parvalbumin in interneurons and PCs. 
Chattopadhyaya and Cristo also suggested that seizure threshold may be 
lowered by changes in the GABA function since GABAergic abnormalities were 
found with high comorbidity rate of autism and epilepsy (Chattopadhyaya & Di 
Cristo, 2012).    
Cerebellum abnormalities have been reported in many animal and human 
studies. Substantially, it is easier to investigate ASD phenotypes in KO animal 
studies than in human post-mortem tissues due to accessibility and a limited 
supply of human brain tissue. This limitation contributes to the depth of further 
exploration using real ASD cases, so we have to rely on transgenic animal 
models that are closest to ASD phenotypes. Han et al. observed social 
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impairment and other core ASD features in a mice model, Scn1A+/-. They found 
GABAergic impairment in the forebrain where this gene encodes for voltage-
gated sodium channel (Nav1.1). By adding low doses of clonazepam, social 
behavior and fear memory impairment was restored. They also stated that these 
transgenic mice have abnormal action potentials in the interneurons located in 
the hippocampus and in Purkinje cells as well as decreased Na+ currents (Han et 
al., 2012). One potential methodological limitation in this current study is that the 
thresholding of silver grains during the quantitative analysis may be subjective 
because the thresholding is done manually and can be influenced by bias. 
However, in a pilot quantification, we confirmed that the number of pixels 
measured after thresholding was correlated with the actual number of silver 
grains.  
In summary, our study provides further evidence for cerebellum 
abnormalities, specifically with the PCs, in autism. Furthermore, GABAergic 
interneurons function is very complex due to the existence of subtypes with 
varying morphology and physiological components (Chattopadhyaya & Di Cristo, 
2012). In another study involving human cerebellum tissue, GAD65 mRNA was 
labeled on two dentate cell subtypes: large and small. Only the large dentate 
cells in autistic sections had reduced GAD65 labeling. This further proves the 
heterogeneity of ASD and the selectivity of altered inhibitory and excitatory 
pathways in the cerebellum in ASD (Yip, Soghomonian, & Blatt, 2009).   
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Our experiment revealed a statistically significant reduction in the PV 
mRNA levels in Purkinje cells of autistic post-mortem sections compared to 
control cases. In addition, no significant difference was reported between seizure 
and no seizure groups within the autism sections. Finally, no correlation was 
presented between post-mortem interval (PMI) and PV mRNA levels while a 
weak negative correlation was observed in terms of age and PV mRNA levels in 
both groups. Our study opens new avenues for future research to better 
understand the inhibitory pathways in the cerebellum as well as to gain a deeper 
understanding of the pathophysiology of PCs in autism. One possible future 
study could look at the loss of PCs and different calcium binding protein or 
transporters found specifically on PCs and try to see if ASD symptoms can be 
alleviated using agents targeting those pathways. Combining earlier studies 
along with other findings can clarify the pathophysiological implications of 
parvalbumin expression in ASD and GABAergic circuitry in the entire brain. 
Ultimately these research studies will get a few steps closer to finding other 
innovative therapies for individuals suffering from ASD.   
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Murphy on the neural pathways of a gastropod, Helisoma Trivolvis, and an 
inorganic dye called Ruthenium Red. Dr. A. Don Murphy also received 
$1500 towards his laboratory. 
 
Chancellor’s Student Service & Leadership Award (2009) 
 Awarded for my Volunteering commitment and service to the University of 
IL at Chicago and to the community.  
 
Distinction for Commitment in NSCS for Leadership, Service, & 
Scholarship (2009) 
 Was awarded $200 for my commitment and volunteering services in the 
National Society of Collegiate Scholars organization.  
 
Recognition for valuable participation in Emerging Leaders Program (2008)  
 
The National Society of Collegiate Scholars Honors (2008) 
 
Science Olympiad Medals (2006 & 2007) 
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 Was awarded 2nd place medal for Ecology in the Regional competition in 
2006. 
 Won 1st place in Genetics and Biology for both Regional and State 
Competition in 2007.   
 
Mu Alpha Theta Honors – National High School and Two-Year College 
Mathematics Honor Society (2006) 
 Joined with honors due to my academic success. Helped students with 
trigonometry, algebra, and geometry.  
 
PROFESSIONAL EXPERIENCE 
Carle Foundation Hospital, Urbana IL (Aug 2012 – Apr 2014) 
Sterile Processing and Distribution (SPD) Technician 
 Trained new employees in each area of the department. Worked with OR 
nurses to ensure new SPD staff received adequate training. Created 
training videos and instructions on how to restock Omni cells in OR, clean 
endoscopes, and sterilize plasma and steam instruments. Promoted to lead 
position for evening shift and night shift in the absence of supervisor. 
Selected supplies, processed trays, cleaned and sterilized instruments for 
all surgeries in OR. Answered phone and filled requests for other floors in 
the hospital.  
 
Consolidated Communications Call Center, Mattoon-Champaign IL (Mar 
2011 – Aug 2012) 
         Customer Call Center Operator 
 Provided 24/7 live answering service and after-hours emergencies services 
to local businesses in Central IL. Helped with tech support for Volo 
Broadband and CMI Broadband. Placed substitute teachers for Springfield, 
Urbana, and Oswego school districts.  
 
Bath & Body Works, Champaign IL (Jun 2010 – Mar 2011)  
Floor Sales Associate 
 Performed cashier duties and assisted customers finding items matching 
their preferences. Replenished under-stock cabinets and helped set up 
decorations for new upcoming themes. 
 
America Reads Challenge (ARC), Chicago IL (Aug – Dec 2010) 
 Tutor 
 Tutored 2nd grade students in math, reading, and grammar at the Galileo 
Scholastic Academy for Math and Science. Graded tests and homework. 
Worked one-on-one with students for homework and test preparations.  
 
RESEARCH  
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Boston University – School of Medicine, Boston, MA (May 2015 – Present) 
 Graduate Research Student   
 Thesis work with post-mortem human cerebellum tissue and radioisotope 
markers to identify structures within Purkinje cells in cerebellum.     
 
University of Illinois – Dept. of Biological Sciences Snail Lab, Chicago, IL 
(Apr 2009 – Dec 2010) 
 Undergraduate Research Assistant   
 Completed a Capstone research project on the neural effects of ruthenium 
red dye on the salivary gland cells in Dr. A. Don Murphy’s Lab. Finalized a 
dissection guideline for other students for BIO 489 and assisted them with 
recordings of brain activity. Learned to properly dissect snail salivary 
glands and record brain activity via electrodes. Performed lab duties such 
as feeding snails, cleaning tanks and autoclaving gravel and equipment.  
 
VOLUNTEER 
Anatomy and Neurobiology Graduate Student Committee (Sep 2014 – 
Present) 
 Master Student Representative for academic year 2015-2016. 
 Organizing a social event after orientation in September 2015 for incoming 
students. 
 
Graduate and Professional Leadership Council - Boston University School 
of Medicine, Boston, MA 
Student Representative for Vision and Dental Insurance for Graduate 
Students (April 2015 – Present) 
 Research and collect information on better vision and dental insurance for 
graduate students.  
 
Carle Foundation Hospital, Champaign, IL  
Carle Auditory Oral School (Feb 2011 – April 2014) 
 Helped hearing impaired students reach “target” words for language skills 
development. Assisted teachers during class, lunch, nap, and recess with 
any duties and supervision. 
Pediatrics Unit (May – Aug 2012) 
 Cleaned play rooms and stocked nurses’ stations and carts. Transported 
patients after discharge.  Supervised patients in the game room. Fed 
pediatric patients who were in social care. Help make arts and crafts 
projects for children. 
Emergency (May 2011 – Aug 2011) 
 Attended to patients who waited in the hallway for rooms and gave them 
blankets. Helped nurses with lifting patients onto beds and wheelchairs. 
Stocked supplies in each room and in the cabinets in the hallway. Cleaned 
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the equipment and beds in between patients. Stocked the oxygen room 
with full tanks. 
Clinical Observational Unit (Jun – Aug 2010) 
 Assisted nurses with any clerical tasks and front desk duties such as 
answering phones, transferring calls to nurses’ charge phones, answering 
patient call lights, and restocking forms. Sanitized beds and IV equipment 
in between patient change.  
PACU (Jun – Aug 2010) 
 Took patients’ temperatures after they came out of surgeries and placed 
warm blankets on patients. Cleaned equipment in-between patients and 
stocked any shelves with supplies and warm blankets. Helped transport 
patients to other units. Provided bedside company to patients who were 
waiting for rooms in other units.  
 
Champaign County Christian Health Care (CCCHC), Champaign IL  
Triage (Jun – Aug 2012) 
 Recorded patients’ blood pressure, heart rate, breathing rate, height, 
weight, and patient history. 
Hospitality Greeter/Client Flow (Jul – Aug 2009; Jun – Aug 2010; Jan 
2011– Jun 2012)   
 Managed patient flow from triage, physicians, social work, and discharge. 
Checked in patients and provided assistance with patient forms. 
 
University of IL at Chicago - Music Therapy, Chicago IL (Feb 2009 – June 
2009) 
 Played clarinet for the patients and the staff at the Johnson R. Bowman 
Health Center at Rush University Medical Center. 
 
Rush University Medical Center, Chicago IL (Apr 2009 – Dec 2010) 
 Served as a wheelchair patient transporter. Administered help services 
including delivering packages, refilling water, and carrying out any tasks for 
nurses. 
 
Jordan James Boys & Girls Family Center, Chicago IL (Nov 2007 – Apr 
2008) 
 Supervised Elementary and Middle school children during extracurricular 
activities and classroom. Tutored students with homework.    
 
SHADOWING 
Boston Medical Center (May 2015 – Present) 
 Observed Thai Q. Vu, Chief PA-C in the Neurosurgery department and his 
interactions with other PAs and physicians.  
 
Education to Careers/Professional Programs (Oct 2006 – Feb 2007) 
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 Shadowed Dr. Bradley Morgan, a pathologist, at Carle Foundation 
Hospital. Observed many autopsies done by Dr. Morgan. Autopsies 
included an amputated leg, breast tissue, gallbladders, and livers. Also 
shadowed various sections of the pathology lab such as the hematology, 
microbiology, histology, and cytology.  
